0.8900USD+26.29%Mkt Cap: 107.57M USDP/E: —Last update: 2026-06-10
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an o…
Industry Peers
Biotechnology110.59BUSDP/E 25.9
99.24BDKKP/E 19.1
63.08BUSDP/E 14.7
51.59BEURP/E 33.7
48.23BEURP/E 39.7
38.88BUSDP/E 73.0
31.39BUSDP/E 28.7
31.33BSEKP/E 46.4
Indicators:|
Key Statistics
Company
Market Cap107.57M USD
Enterprise Value106.70M USD
Revenue (TTM)333.14K USD
Gross Profit57.20K USD
Net Income (TTM)-62.42M USD
Revenue/Share0.0060 USD
Last Price0.8900 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.71
PEG—
EV/EBITDA-1.76
EV/Revenue320.29
P/S322.03
P/B-2.61
EPS (TTM)-1.13
EPS (Forward)-0.27
52W Range
0.161023% of range3.390
52W High3.390 USD
52W Low0.1610 USD
Profitability
Gross Margin4.05%
Oper. Margin-11006.82%
EBITDA Margin0.00%
Profit Margin-4416.22%
ROE193.94%
ROA-335.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.83M USD
CapEx (TTM)—
FCF Margin-7645.84%
FCF Yield-23.68%
Net Debt19.44M USD
Net Debt/EBITDA-0.32
Balance Sheet
Debt/Equity-0.94
Current Ratio0.54
Quick Ratio0.27
Book Value/Sh-0.2770 USD
Cash/Share0.0640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 18, 2019
Splits
Last Split1:20
Split DateMar 14, 2024
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)4.167 USD
Target Range0.5000 USD – 6.000 USD
# Analysts3
Ownership
Shares Out.120.86M
Float96.40M
Insiders17.42%
Institutions6.92%
Short Interest
Short Ratio1.9d
Short % Float7.52%
Short % Out.7.52%
Shares Short9.09M
Short (prev mo.)4.69M
Technical
SMA 500.3476 (+156.0%)
SMA 2000.9057 (-1.7%)
Beta0.98
S&P 52W Chg22.64%
Avg Vol (30d)24.17M
Avg Vol (10d)67.53M
Technical Indicators
RSI (14)74.4
MACD0.1428
MACD Signal0.1200
MACD Hist.+0.0228
BB Upper1.068 USD
BB Middle0.5411 USD
BB Lower0.0137 USD
BB Width194.94%
ATR (14)0.0977 USD
Vol Ratio (20d)0.66x